Internal Medicine, Hematology & Oncology · Torrance, CA
NPI
1487647293
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
23441 Madison St Ste 215
Torrance, CA, 90505
Phone (424) 375-7209
Groups this clinician bills Medicare through
Medicare paid, 2024
$102K
8,924 services
Medicare patients, 2024
21
Average age 65
Drug cost, 2024
$3.4M
1,029 prescriptions
Company payments, 2023
$18.89
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Arshad Ahad was code J7030 (infusion, normal saline solution , 1000 cc), 34 times for 11 patients. In total Arshad Ahad billed 8,924 services in 39 codes, and Medicare paid $102K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-09-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J7030 Infusion, normal saline solution , 1000 cc | Office | 34 | 11 | $2.00 | $68.09 |
By year: 2022 $12K for 1,356 services; 2023 $17K for 1,093 services; 2024 $102K for 8,924 services.
Medicare prescription drug claims, 2024
In 2024, the drug Arshad Ahad prescribed most often to Medicare patients was Anastrozole, with 161 prescriptions and refills. In total Arshad Ahad wrote 1,029 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 161 | 475 | 51 | $4,450 |
| Abiraterone Acetate Generic | 126 | 165 | 22 | $25K |
| Prednisone Generic | 75 | 194 | 29 | $721 |
| Brukinsa Zanubrutinib | 45 | 45 | Under 11 | $429K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 43 | 43 | 14 | $971 |
| Dexamethasone Generic | 39 | 43 | 16 | $591 |
| Letrozole Generic | 34 | 85 | Under 11 | $613 |
| Hydroxyurea Generic | 29 | 79 | Under 11 | $1,078 |
| Potassium Chloride Generic | 27 | 28 | 11 | $386 |
| Tamoxifen Citrate Generic | 24 | 71 | Under 11 | $644 |
| Xtandi Enzalutamide | 20 | 20 | Under 11 | $242K |
| Kisqali Ribociclib Succinate | 20 | 20 | Under 11 | $315K |
| Ondansetron Hcl Generic | 16 | 16 | Under 11 | $146 |
| Prochlorperazine Maleate Generic | 15 | 15 | Under 11 | $178 |
| Calquence Acalabrutinib Maleate | 15 | 15 | Under 11 | $216K |
Brand drugs: 241 claims; generic drugs: 788 claims; opioid claims: 62.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Arshad Ahad $18.89 ($18.89 in general payments such as food, travel and fees) from 1 company. The largest payer was Boston Scientific Corporation with $18.89.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 1 | $18.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.